C. Currie

First name
C.
Middle name
J.
Last name
Currie
Bannister, C. A., Poole, C. D., Jenkins-Jones, S., Morgan, C. L., Elwyn, G., Spasic, I., & Currie, C. J. (2014). External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care. http://doi.org/10.2337/dc13-1159
Holden, S. E., Gale, E. A., Jenkins-Jones, S., & Currie, C. J. (2014). How many people inject insulin? UK estimates from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12260
Currie, C. J., Berni, E., Jenkins-Jones, S., Poole, C. D., Ouwens, M., Driessen, S., et al. (2014). Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. Bmj. http://doi.org/10.1136/bmj.g5493
Morgan, C. L., Mukherjee, J., Jenkins-Jones, S., Holden, S. E., & Currie, C. J. (2014). Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12302
Bannister, C. A., Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., et al. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. http://doi.org/10.1111/dom.12354
Morgan, C. L., Mukherjee, J., Jenkins-Jones, S., Holden, S. E., & Currie, C. J. (2014). Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality. Diabetes Obes Metab. http://doi.org/10.1111/dom.12306
Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Schernthaner, G., & Currie, C. J. (2015). Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab. http://doi.org/10.1111/dom.12412
Baxter, G., Morgan, C. L., Jenkins-Jones, S., Currie, C. J., & Schultewolter, D. (2015). Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study. Value Health. http://doi.org/10.1016/j.jval.2015.09.2385
Berni, E., Scott, L. A., Jenkins-Jones, S., de Voogd, H., Rocha, M. S., Butler, C. C., et al. (2016). Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study. Antibiotics (Basel). http://doi.org/10.3390/antibiotics5030025
Holden, S. E., Jenkins-Jones, S., & Currie, C. J. (2016). Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study. PLoS One. http://doi.org/10.1371/journal.pone.0153594